Clinical Trial Update: Decision Impact Study to Measure the Influence of DECIPHER on Treatment Recommendations

View source ↗

Summary

This document reports on a completed decision impact study assessing whether the DECIPHER genomic classifier influences prostate cancer treatment recommendation…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: GenomeDx Biosciences Corp | Conditions: Prostate Cancer | Status: COMPLETED